Sort   by:  
 Page size 
UnknownKYNU-related transcriptome profile and clinical outcome from 2994 breast tumors.
Not available
S-EPMC10293725 | biostudies-literature
UnknownBiallelic variants in KYNU cause a multisystemic syndrome with hand hyperphalangism.
Not available
S-EPMC10521254 | biostudies-literature
UnknownKYNU as a Biomarker of Tumor-Associated Macrophages and Correlates with Immunosuppressive Microenvironment and Poor Prognosis in Gastric Cancer.
Not available
S-EPMC10635752 | biostudies-literature
UnknownKynu inhibition mitigates bile duct ischemic injury by rewiring tryptophan metabolism to restore tight junction integrity.
Not available
S-EPMC12366207 | biostudies-literature
UnknownInflammation-Induced Mucosal KYNU Expression Identifies Human Ileal Crohn's Disease.
Not available
S-EPMC7290775 | biostudies-literature
UnknownM2 macrophage-secreted KYNU promotes stemness remodeling and malignant behavior in endometrial cancer via the SOD2-mtROS-ERO1α-UPRER axis.
Not available
S-EPMC12231660 | biostudies-literature
UnknownDifferential Gene Expression and Methylation Analysis of Melanoma in TCGA Database to Further Study the Expression Pattern of KYNU in Melanoma.
Not available
S-EPMC9329910 | biostudies-literature
ProteomicsOrgan protection by caloric restriction depends on activation of the de novo NAD+ synthesis pathway
Therapeutic strategies to treat acute kidney injury (AKI) are lacking. Preconditioning by hypoxia (HP) and caloric restriction (CR) is highly protective in rodent AKI models. The underlying molecular mechanisms are unknown. A comparative transcriptome analysis after HP and CR identified Kynureninase...
ORGANISM(S): Mus musculus (Mouse) 
2023-02-13 | PXD038328 | Pride
Kynu Hypoxia Caloric restriction Acute kidney injury Kynureninase Nad+ 
UnknownNetwork pharmacology identifies AKR1C3 and KYNU as potential targets of Astragalus Membranaceus and Ephedra in pediatric obesity-associated asthma.
Not available
S-EPMC12804807 | biostudies-literature
UnknownKYNU is a potential metabolic-related biomarker for nasopharyngeal carcinoma by Raman spectroscopy, metabolomics, and transcriptomics analysis.
Not available
S-EPMC12373589 | biostudies-literature
Sort   by:  
 Page size